Clinical Trial Update: SS-HH-OCT as a Novel Diagnostic Modality for Early-Onset Retinal Dystrophies (EORDs) [NA]

View source ↗

Summary

Clinical trial evaluating SS-HH-OCT as a novel diagnostic modality for early-onset retinal dystrophy conditions; study currently recruiting at Duke University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Early-onset Retinal Dystrophy
• Retinal Dystrophy

Snippet

Sponsor: Duke University | Conditions: Retinal Dystrophies | NA | Status: RECRUITING